Please assess the completion status of the following clinical trial:

Trial Title: Oregano Ointment vs. Standard Treatment for Pediatric Atopic Dermatitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male or non-pregnant female subjects aged 2-17 years of age.~* Individuals must be diagnosed with acute-subacute AD regardless of the study.~* Written informed consent must be obtained from all patients or caregivers.~* Women of childbearing potential (WOCBP) must be willing to practice effective contraception for the duration of study treatment.~* Subjects must be willing and able to comply with study conditions, properly apply or have caregivers apply topical medications to the selected body sites, as well as return to the clinic for required visits.~* Subject caregivers must be willing and able to perform ADQ assessment test.~Exclusion Criteria:~* Individuals who are immune-compromised or suffering from infectious disease, malignant disease, are known to be HIV+ or present with a general reduced level of health.~* Individuals diagnosed with underlying dermatological conditions in addition to AD.~* Individuals with a chronic pre-existing disease such as diabetes mellitus or others that in the opinion of the investigator would preclude their participation in the study.~* Individuals who are pregnant, nursing mothers, or subjects planning a pregnancy during the course of the study.~* Subjects/caregivers who are unable to communicate or comply with study conditions due to language disability, poor mental development, or impaired cerebral function.~* Individuals who are simultaneously enrolled in another clinical drug or device research study.~* Individuals with a history of chronic steroid use.~* Individuals needing to concurrently use topical agents, medicinal products containing corticosteroids, or immunosuppressants.~* Individuals who have received systemically administered corticosteroids and/or antihistamines 2 weeks prior to the start of study.~* Individuals undergoing light therapy.~* Individuals who have been treated with another investigation device or drug within 30 days prior to study enrollment.~* Individuals with a known allergy to oregano.

- Gender: ALL
- Minimum Age: 2 Years
- Maximum Age: 17 Years
- Healthy Volunteers: f

Study Arms:
- Standard: Hydrocortisone 1% ointment (Type: ACTIVE_COMPARATOR): Intervention: hydrocortisone 1% ointment will be applied to one patient's forearm
- Experimental: oregano extract cream (Type: EXPERIMENTAL): Intervention: Oregano extract cream for mild to moderate atopic dermatitis will be applied to the other patient's forearm

Based on this trial design, predict the completion outcome and termination type (if applicable).